Comparison
46 Xx Disorder Of Sex Development Induced By Androgens Excess C5680227 vs 3 Methylglutaconic Aciduria Type 3 C0574084
Clinical comparison between 46 XX Disorder OF Sex Development Induced BY Androgens Excess and 3 Methylglutaconic Aciduria Type 3 for differential diagnosis and treatment planning.
46 Xx Disorder Of Sex Development Induced By Androgens Excess C5680227
A condition where an XX individual has excess male hormones causing atypical genital development. It affects both newborns and older individuals. Treatment may involve hormone management and surgical options.
3 Methylglutaconic Aciduria Type 3 C0574084
A genetic metabolic disorder that primarily affects the nervous system, often causing vision problems, movement difficulties, and cognitive challenges. Treatment involves supportive therapies and regular monitoring.
6 comparison axes
Onset
46 Xx Disorder Of Sex Development Induced By Androgens Excess C5680227
0-null
3 Methylglutaconic Aciduria Type 3 C0574084
1-10
Onset patterns differ
Severity
46 Xx Disorder Of Sex Development Induced By Androgens Excess C5680227
severe
3 Methylglutaconic Aciduria Type 3 C0574084
moderate
Different severity levels
Chronic
46 Xx Disorder Of Sex Development Induced By Androgens Excess C5680227
Chronic
3 Methylglutaconic Aciduria Type 3 C0574084
Chronic
Differing course
Communicable
46 Xx Disorder Of Sex Development Induced By Androgens Excess C5680227
No
3 Methylglutaconic Aciduria Type 3 C0574084
No
Different transmission
Body System
46 Xx Disorder Of Sex Development Induced By Androgens Excess C5680227
reproductive
3 Methylglutaconic Aciduria Type 3 C0574084
metabolic
Same/different system
Category
46 Xx Disorder Of Sex Development Induced By Androgens Excess C5680227
endocrine
3 Methylglutaconic Aciduria Type 3 C0574084
metabolic
Different category
Bottom line
46-xx-disorder-of-sex-development-induced-by-androgens-excess-C5680227 and 3-methylglutaconic-aciduria-type-3-C0574084 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 46 Xx Disorder Of Sex Development Induced By Androgens Excess C5680227 | 3 Methylglutaconic Aciduria Type 3 C0574084 | Discriminating power |
|---|---|---|---|
| Genital development | Atypical genital development may be present in an XX individual. | Genital atypicality is not a described feature. | High |
| Vision and movement | Vision loss and movement disorder are not established features. | Vision problems and movement difficulties are commonly described. | High |
| Cognitive function | Cognitive impairment is not established by the supplied description. | Cognitive challenges may occur. | Moderate |
When to favor each condition
Choose 46 Xx Disorder Of Sex Development Induced By Androgens Excess C5680227 when
XX individual with atypical genitalia and suspected androgen excess
The presentation matches a disorder of sex development rather than a neurometabolic disease.
High
Endocrine evaluation is the main clinical need
Hormone assessment and specialist interpretation are central.
Moderate
No neurologic or visual syndrome is evident
Absence of those features makes the metabolic diagnosis less likely, but does not prove it.
Low
Choose 3 Methylglutaconic Aciduria Type 3 C0574084 when
Childhood-onset vision, movement, or cognitive problems
These features align with the described nervous-system involvement.
High
Metabolic workup suggests organic aciduria
Biochemical findings should be interpreted by a metabolic specialist.
Moderate
No evidence of androgen-related genital difference
This reduces support for the left condition but is not diagnostic alone.
Low
How key tests differ
| Test | 46 Xx Disorder Of Sex Development Induced By Androgens Excess C5680227 | 3 Methylglutaconic Aciduria Type 3 C0574084 | Interpretation |
|---|---|---|---|
| Karyotype or sex-chromosome testing | 46,XX may be relevant to classification. | No characteristic sex-chromosome result is established. | A karyotype does not by itself prove androgen excess or exclude metabolic disease. |
| Androgen or endocrine evaluation | Excess androgen activity is the defining concept. | Androgen excess is not an established feature. | Exact cutoffs are not supplied and require clinician interpretation. |
| Urine organic acids | No characteristic organic-acid pattern is established. | 3-methylglutaconic acid elevation may support the diagnosis. | An abnormal metabolite result is not itself a complete diagnosis. |
Prognosis comparison
46 Xx Disorder Of Sex Development Induced By Androgens Excess C5680227
- Outcome
- Chronic condition; individual outcome is not established here.
- Factors
- Degree of androgen effect, associated diagnosis, and access to specialist care.
3 Methylglutaconic Aciduria Type 3 C0574084
- Outcome
- Chronic neurometabolic condition with variable impact.
- Factors
- Vision, movement, cognition, and supportive-care needs.
Time frame: Long-term; exact course is not established by these data.
Do not infer mortality or a fixed prognosis from severity labels alone.
Complications comparison
| Complication | Presentation |
|---|---|
| Genital and reproductive effects | Atypical development and possible need for hormone or surgical care. Not an established complication. Decisions require specialist counseling; outcomes are not specified here. |
| Neurologic disability | Not established. Movement and cognitive difficulties may occur. Severity varies and should not be assumed from the label alone. |
| Vision impairment | Not established. Vision problems are a recognized concern. Ophthalmology follow-up is appropriate when clinically indicated. |
Patient education highlights
- HighDifferent conditions
These diagnoses involve different body systems and require different specialist teams.
- HighTest results
An abnormal hormone or metabolite result needs clinician interpretation and is not automatically a diagnosis.
- MediumSupportive care
Care may include hormone management or supportive neurologic, visual, and developmental therapies as indicated.